Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-15

Clinical Trial Update: Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing clonidine versus morphine as the primary therapy for Neonatal Abstinence Syndrome; the study is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)
  • Morphine (morphine)

Snippet

Sponsor: The Cooper Health System | Conditions: Neonatal Abstinence Syndrome | Phase 4 | Status: ACTIVE_NOT_RECRUITING